title: OS Command Injection vulnerability affecting BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023
description: An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary command execution.
problem types: CWE-78 Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection')
affected:
{
vendor: Dassault Systèmes
product: BIOVIA Materials Studio products
versions:
status: affected, version: BIOVIA 2021 Golden
status: affected, version: BIOVIA 2022 Golden
status: affected, version: BIOVIA 2023 Golden
defaultStatus: unaffected
}
metrics:
format: CVSS
scenarios: GENERAL
cvssV3_1: [
version: 3.1
attackVector: NETWORK
attackComplexity: LOW
privilegesRequired: LOW
userInteraction: NONE
scope: UNCHANGED
confidentialityImpact: HIGH
integrityImpact: HIGH
availabilityImpact: HIGH
baseSeverity: HIGH
baseScore: 8.8
vectorString: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
]